What was the market valuation of the US chronic kidney-disease market in 2024?

The market valuation was $8.2 Billion in 2024. Read More

What is the projected market valuation for the US chronic kidney-disease market by 2035?

The projected valuation for 2035 is $15.0 Billion. Read More

What is the expected CAGR for the US chronic kidney-disease market during the forecast period 2025 - 2035?

The expected CAGR during this period is 5.64%. Read More

Which companies are considered key players in the US chronic kidney-disease market?

Key players include Fresenius Medical Care, DaVita Inc., Baxter International Inc., and Amgen Inc. Read More

What are the main segments of the US chronic kidney-disease market?

The main segments include Diagnosis, Treatment, Indication, and End User. Read More

What was the valuation of the Diagnosis segment in 2024?

The Diagnosis segment had a valuation of $5.5 Billion in 2024. Read More

What is the projected valuation for the Treatment segment by 2035?

The projected valuation for the Treatment segment by 2035 is $15.0 Billion. Read More

How much is the Drugs segment expected to grow from 2024 to 2035?

The Drugs segment is expected to grow from $3.5 Billion in 2024 to $6.0 Billion by 2035. Read More

What is the valuation of the End User segment in 2024?

The End User segment was valued at $8.2 Billion in 2024. Read More

Which indication has the highest projected growth in the US chronic kidney-disease market?

High Blood Pressure is projected to grow from $3.0 Billion in 2024 to $5.5 Billion by 2035. Read More

US Chronic Kidney Disease Market

ID: MRFR/Pharma/14107-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Chronic Kidney Disease Market Research Report: Size, Share, Trend Analysis By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant), By Indication (Type 1 Or Type 2 Diabetes, High Blood Pressure, Polycystic Kidney Disease) and By End Users (Hospital & Clinics, Diagnostic Centers) - Growth Outlook & Industry Forecast 2025 To 2035

US Chronic Kidney Disease Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Diagnosis (USD Billion)
  1. 4.1.1 Blood Test
  2. 4.1.2 Urine Test
  3. 4.1.3 Imaging Test
  4. 4.1.4 Kidney Biopsy
2. 4.2 Medical Device, BY Treatment (USD Billion)
  1. 4.2.1 Drugs
  2. 4.2.2 Dialysis
  3. 4.2.3 Kidney Transplant
3. 4.3 Medical Device, BY Indication (USD Billion)
  1. 4.3.1 Type 1 Or Type 2 Diabetes
  2. 4.3.2 High Blood Pressure
  3. 4.3.3 Polycystic Kidney Disease
4. 4.4 Medical Device, BY End User (USD Billion)
  1. 4.4.1 Hospital & Clinics
  2. 4.4.2 Diagnostic Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Fresenius Medical Care (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 DaVita Inc. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Baxter International Inc. (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Amgen Inc. (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Novartis AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Roche Holding AG (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sanofi S.A. (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck & Co., Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AbbVie Inc. (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS
3. 6.3 US MARKET ANALYSIS BY TREATMENT
4. 6.4 US MARKET ANALYSIS BY INDICATION
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Billion)
14. 6.14 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Billion)
16. 6.16 MEDICAL DEVICE, BY INDICATION, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY INDICATION, 2024 TO 2035 (USD Billion)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.2.3 BY INDICATION, 2025-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Diagnosis (USD Billion, 2025-2035)

Blood Test
Urine Test
Imaging Test
Kidney Biopsy

Medical Device By Treatment (USD Billion, 2025-2035)

Drugs
Dialysis
Kidney Transplant

Medical Device By Indication (USD Billion, 2025-2035)

Type 1 Or Type 2 Diabetes
High Blood Pressure
Polycystic Kidney Disease

Medical Device By End User (USD Billion, 2025-2035)

Hospital & Clinics
Diagnostic Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”